Endobrevin, a Novel Synaptobrevin/VAMP-Like Protein Preferentially Associated with the Early Endosome

Membrane Biology Laboratory, Institute of Molecular and Cell Biology, Singapore 117609, Singapore.
Molecular Biology of the Cell (Impact Factor: 4.47). 07/1998; 9(6):1549-63. DOI: 10.1091/mbc.9.6.1549
Source: PubMed


Synaptobrevins/vesicle-associated membrane proteins (VAMPs) together with syntaxins and a synaptosome-associated protein of 25 kDa (SNAP-25) are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. We report here the molecular, biochemical, and cell biological characterization of a novel member of the synaptobrevin/VAMP family. The amino acid sequence of endobrevin has 32, 33, and 31% identity to those of synaptobrevin/VAMP-1, synaptobrevin/VAMP-2, and cellubrevin, respectively. Membrane fractionation studies demonstrate that endobrevin is enriched in membrane fractions that are also enriched in the asialoglycoprotein receptor. Indirect immunofluorescence microscopy establishes that endobrevin is primarily associated with the perinuclear vesicular structures of the early endocytic compartment. The preferential association of endobrevin with the early endosome was further established by electron microscopy (EM) immunogold labeling. In vitro binding assays show that endobrevin interacts with immobilized recombinant alpha-SNAP fused to glutathione S-transferase (GST). Our results highlight the general importance of members of the synaptobrevin/VAMP protein family in membrane traffic and provide new avenues for future functional and mechanistic studies of this protein as well as the endocytotic pathway.

Full-text preview

Available from:
  • Source
    • "2010; Gutierrez et al., 2004; Klionsky et al., 2012; Wong et al., 1998). The apparently minimal impact of Plac8 deficiency on normal physiologic processes (Ledford et al., 2007) fits well with the mutant phenotypes of several other genes involved in the autophagosome maturation including Lamp2 and Tecpr1 (Chen et al., 2012; Eskelinen et al., 2002; Ogawa et al., 2011; Tanaka et al., 2000). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mutations in p53 and RAS potently cooperate in oncogenic transformation, and correspondingly, these genetic alterations frequently coexist in pancreatic ductal adenocarcinoma (PDA) and other human cancers. Previously, we identified a set of genes synergistically activated by combined RAS and p53 mutations as frequent downstream mediators of tumorigenesis. Here, we show that the synergistically activated gene Plac8 is critical for pancreatic cancer growth. Silencing of Plac8 in cell lines suppresses tumor formation by blocking autophagy, a process essential for maintaining metabolic homeostasis in PDA, and genetic inactivation in an engineered mouse model inhibits PDA progression. We show that Plac8 is a critical regulator of the autophagic machinery, localizing to the lysosomal compartment and facilitating lysosome-autophagosome fusion. Plac8 thus provides a mechanistic link between primary oncogenic mutations and the induction of autophagy, a central mechanism of metabolic reprogramming, during PDA progression.
    Cell Reports 04/2014; 7(4). DOI:10.1016/j.celrep.2014.03.061 · 8.36 Impact Factor
  • Source
    • "The other exocytotic proteins that mediate newcomer SGs and SG-SG fusions remain to be defined. VAMP8 was first identified as an endosomal SNARE (endobrevin ) involved in endosomal fusion (Antonin et al., 2000a, 2000b; Wong et al., 1998). It was then implicated in GLUT4 exocytosis (Zhao et al., 2009) and endocytosis (Williams and Pessin, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Optimal insulin secretion required to maintain glucose homeostasis is the summation of total pancreatic islet β cell mass and intrinsic secretory capacity of individual β cells, which are regulated by distinct mechanisms that could be amplified by glucagon-like-peptide-1 (GLP-1). Because of these actions of GLP-1 on islet β cells, GLP-1 has been deployed to treat diabetes. We employed SNARE protein VAMP8-null mice to demonstrate that VAMP8 mediates insulin granule recruitment to the plasma membrane, which partly accounts for GLP-1 potentiation of glucose-stimulated insulin secretion. VAMP8-null mice also exhibited increased islet β cell mass from increased β cell mitosis, with β cell proliferative activity greatly amplified by GLP-1. Thus, despite the β cell exocytotic defect, VAMP8-null mice have an increased total insulin secretory capacity, which improved glucose homeostasis. We conclude that these VAMP8-mediated events partly underlie the therapeutic actions of GLP-1 on insulin secretion and β cell growth.
    Cell metabolism 07/2012; 16(2):238-49. DOI:10.1016/j.cmet.2012.07.001 · 17.57 Impact Factor
  • Source
    • "Similarly, overexpression of STX4 but not STX2 or STX3 inhibited exocytosis (Paumet et al., 2000). Concerning VAMP proteins several recent studies reported a role of VAMP8, a v-SNARE initially named endobrevin (Wong et al., 1998) due to its localization and function in endosomes and endosomal fusion. The latter underlines the close connection between the endocytic and secretory compartments in mast cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mast cells are known as inflammatory cells which exert their functions in allergic and anaphylactic reactions by secretion of numerous inflammatory mediators. During an allergic response, the high-affinity IgE receptor, FcεRI, becomes cross-linked by receptor-bound IgE and antigen resulting in immediate release of pre-synthesized mediators - stored in granules - as well as in de novo synthesis of various mediators like cytokines and chemokines. Soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptors (SNARE) proteins were found to play a central role in regulating membrane fusion events during exocytosis. In addition, several accessory regulators like Munc13, Munc18, Rab GTPases, secretory carrier membrane proteins, complexins, or synaptotagmins were found to be involved in membrane fusion. In this review we summarize our current knowledge about the SNARE machinery and its mechanism of action in mast cell secretion.
    Frontiers in Immunology 06/2012; 3:143. DOI:10.3389/fimmu.2012.00143
Show more